Cantor Fitzgerald Comments on SMMT FY2026 Earnings
Summit Therapeutics Inc. (NASDAQ:SMMT – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2026 EPS estimates for Summit Therapeutics in a research note issued on Monday, June 9th. Cantor Fitzgerald analyst E. Schmidt anticipates that the company will earn ($0.62) per share for the year. Cantor Fitzgerald currently has a “Overweight” rating on […]
Summit Therapeutics Inc. (NASDAQ:SMMT – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2026 EPS estimates for Summit Therapeutics in a research note issued on Monday, June 9th. Cantor Fitzgerald analyst E. Schmidt anticipates that the company will earn ($0.62) per share for the year. Cantor Fitzgerald currently has a “Overweight” rating on […]
